Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Pingsheng, Chen"'
Autor:
Jing Huang, Ming Ding, Yuan Lu, Lu Xu, Yu Zhang, Shuhua Han, Xiaoli Zhu, Yiping Li, Pingsheng Chen
Publikováno v:
Cell Death and Disease, Vol 14, Iss 12, Pp 1-11 (2023)
Abstract With the widespread development of chest computed tomography (CT), the detection rate of pulmonary nodules has increased; therefore, the classification of benign vs. malignant nodules has become a common problem in the clinic. MicroRNA, a po
Externí odkaz:
https://doaj.org/article/cdeaf7aa788d467dbecc201ec3ad0230
Autor:
Yu Zhang, Chuanbing Shi, Yiqiong Yang, Xiuxiu Hu, Haifeng Ni, Li Li, Zhengyuan Cheng, Jing Huang, Pingsheng Chen
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Renal interstitial fibrosis (RIF) is a key feature of progressive chronic kidney disease (CKD), characterized by tubular epithelial cell (TEC) hypoxia and peritubular capillary (PTC) rarefaction. However, the mechanisms underlying these proc
Externí odkaz:
https://doaj.org/article/54a1be1096ff45308fdc26eb99e04ae5
Autor:
Xin Yang, Yuqiu Liu, Xiaodong Zhu, Pingsheng Chen, Xiaotong Xie, Tian Xu, Xiaoliang Zhang, Yu Zhao
Publikováno v:
Renal Failure, Vol 45, Iss 1 (2023)
AbstractBackground Ectopic calcification (EC) involves multiple organ systems in chronic kidney disease (CKD). Previous CKD-animal models primarily focused on a certain histological abnormality but did not show the correlation with calcified developm
Externí odkaz:
https://doaj.org/article/cc82a8e7b5344584a33f0ba5f8c05fcf
Autor:
Yuhan Cao, Yuanhui Shi, Yanlang Yang, Zhangli Wu, Nana Peng, Jie Xiao, Fan Dou, Jingjing Xu, Wenjun Pei, Cong Fu, Pingsheng Chen, Yuwei Wang
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1966-1976 (2022)
Background Chronic renal disease (CKD) is a common and irreversible loss of renal function. Renal fibrosis reflected the degree of renal dysfunction. However, the current biomarkers only characterize the renal function instead of indicating the fibro
Externí odkaz:
https://doaj.org/article/c3199b257e28462b8013938e1af768e6
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Endobronchial ultrasound (EBUS) elastography has been used in EBUS-guided transbronchial needle aspiration (EBUS-TBNA) to identify malignant lymph nodes based on tissue stiffness. Rapid onsite cytological evaluation (ROSE) has bee
Externí odkaz:
https://doaj.org/article/f237961a69934454969ba5ded5c2a74d
Publikováno v:
BMC Medical Education, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Pathology education provides information on pathology and guides students to become pathologists. Recently, the Ministry of Education of the People’s Republic of China required the establishment of the system of ‘High-quality
Externí odkaz:
https://doaj.org/article/0c0ce522d8994c84bafddcd7ce43343a
Publikováno v:
Epigenetics, Vol 14, Iss 10, Pp 949-960 (2019)
HOXA11, which is a member of the homeobox (HOX) gene family, and its natural antisense transcript (NAT) HOXA11-AS have been reported to be closely related to the development of lung cancer. We aimed to investigate their specific roles in cisplatin (D
Externí odkaz:
https://doaj.org/article/14c8634db527472ab315aa9bcc2012a8
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 53, Iss 4 (2020)
Rab7, an important member of the Rab family, is closely related to autophagy, endocytosis, apoptosis, and tumor suppression but few studies have described its association with renal fibrosis. In the early stage, our group studied the effects of Rab7
Externí odkaz:
https://doaj.org/article/91d999231f23499ca3abd9ee8cc159c2
Autor:
Jing Huang, Ming Ding, Yuan Lu, Lu Xu, Yu Zhang, Shuhua Han, Xiaoli Zhu, Yiping Li, Pingsheng Chen
With the widespread development of chest computed tomography (CT), the detection rate of pulmonary nodules has been increasing, therefore, the judgment of benign and malignant nodules has become a common problem in clinic. MicroRNA, a potential tool,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3ee588eb5eeb3696b4ce35ba2ce5d25
https://doi.org/10.21203/rs.3.rs-2827870/v1
https://doi.org/10.21203/rs.3.rs-2827870/v1
Autor:
Amy B. Heimberger, Gordon B. Mills, Guang Peng, Michelle C. Barton, Pingsheng Chen, Jian Chen, Zhiyong Ding, Francois X. Claret, Meng Gao, XiaoHua Chen, Shan Shao, Qinghua Yu, Zhi-Xiang Xu, Changming Lu, Shao-Cong Sun, Han Liang, Zhicheng Zhou, Abhinav K. Jain, Yiling Lu, Wei Zhao, Kang Jin Jeong, Cynthia Kassab, Dexing Fang, Anantha L. Marisetty, Bojin Su, Jianfeng Shen, Chao Wang, Lulu Wang, Jiyong Liang
Programmed cell death 1 ligand 1 (PD-L1) is a key driver of tumor-mediated immune suppression, and targeting it with antibodies can induce therapeutic responses. Given the costs and associated toxicity of PD-L1 blockade, alternative therapeutic strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fdc45d7f9c7fcf19de03236091b5de6
https://doi.org/10.1158/2326-6066.c.6550231
https://doi.org/10.1158/2326-6066.c.6550231